Penn's Center for Neurodegenerative Disease Research (CNDR) will partner with Johnson & Johnson Pharmaceutical Research and Development, L.L.C., (J&JPRD) to develop algorithms that can identify changes in biomarkers related to disease diagnosis and for monitoring disease progression.

At menopause, many women begin to notice a decline in their attention, organization, and short-term memory. These cognitive symptoms can lead to professional and personal challenges and unwarranted fears of early-onset dementia.

Two reports by addiction researchers at the University of Pennsylvania School of Medicine and the National Institute on Drug Abuse show a drastic shift in prescribing patterns impacting the magnitude of opioid substance abuse in America.

By combining sophisticated mathematical techniques more commonly used by spies instead of scientists with the power and versatility of functional magnetic resonance imaging (fMRI), a Penn neurologist has developed a new approach for studying the inner workings of the brain.

For seniors, voting can be difficult: standing with a walker or cane in the voting booth, struggling to read the tiny print on the ballot or trying to punch the tiny button to vote for the intended candidate. Despite the desire to vote, the typical voting process leaves many seniors disenfranchised, particularly for residents of long term care facilities.

When Medicare hospice eligibility criteria expand in 2011 as part of the Affordable Care Act of 2010, efforts to test whether palliative care and aggressive treatment provided concurrently will be judged based on costs.

PHILADELPHIA – A simple test performed at the sideline of sporting events can accurately detect concussions in athletes, according to study by researchers at the University of Pennsylvania School of Medicine. Current sideline tests can leave a wide amount a brain function untested following concussion.

PHILADELPHIA – Penn Medicine has been selected as one of seven adult field trial sites to test proposed diagnostic criteria for the American Psychiatric Association’s (APA) fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM).

PHILADELPHIA –Researchers at the University of Pennsylvania School of Medicine’s Udall Center for Parkinson's Research have developed the first blood-based biomarker test to predict cognitive decline in Parkinson’s disease (PD).

Gone are the days when a doctor’s only way of helping patients is by treating the disease after symptoms have started.